The 1.8 resolution ternary structure of P. vivax N -myristoyltransferase in complex with IMP-1088 and myristoyl-CoA is presented. IMP-1088 is an N -myristoyltransferase inhibitor from a family of inhibitors that are under investigation as antimalarials.Plasmodium vivax , a significant contributor to global malaria cases, poses an escalating health burden on a substantial portion of the world s population. The increasing spread of P. vivax because of climate change underscores the development of new and rational drug-discovery approaches. The Seattle Structural Genomics Center for Infectious Diseases is taking a structure-based approach by investigating essential enzymes such as N -myristoyltransferase (NMT). P.... More
The 1.8 resolution ternary structure of P. vivax N -myristoyltransferase in complex with IMP-1088 and myristoyl-CoA is presented. IMP-1088 is an N -myristoyltransferase inhibitor from a family of inhibitors that are under investigation as antimalarials.Plasmodium vivax , a significant contributor to global malaria cases, poses an escalating health burden on a substantial portion of the world s population. The increasing spread of P. vivax because of climate change underscores the development of new and rational drug-discovery approaches. The Seattle Structural Genomics Center for Infectious Diseases is taking a structure-based approach by investigating essential enzymes such as N -myristoyltransferase (NMT). P. vivax N -myristoyltransferase ( Pv NMT) is a promising target for the development of novel malaria treatments unlike current drugs, which target only the erythrocytic stages of the parasite. Here, the 1.8 resolution ternary structure of Pv NMT in complex with myristoyl-CoA and IMP-1088, a validated NMT inhibitor, is reported. IMP-1088 is a validated nonpeptidic inhibitor and a ternary complex structure with human NMT has previously been reported. IMP-1088 binds similarly to Pv NMT as to human NMT.
